Nks.lww.com/QAD/A400). Similarly, when comparing `Xpert plus LF-LAM' with `Xpert' testing alone, there were few circumstances in which `Xpert/LF-LAM' algorithm was not considered highly cost-effective. The ICER comparing `Xpert plus LF-LAM' algorithm with `Xpert' was most influenced by the specificity of LF-LAM and lifeexpectancy after TB treatment, but remained cost-effective even at lowest estim